Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates
— Company to Host Conference Call and Webcast Today at 8:00 a.m. EDT —— Recent highlights include successful ZEJULA and […]
nCino Announces Timing of its Second Quarter Fiscal 2021 Results Conference Call
WILMINGTON, N.C., Aug. 13, 2020 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO) will report financial results for its second quarter […]
Golar LNG Limited: Interim results for the period ended June 30 2020
Solid performance from all business divisionsIain Ross, CEO, Golar LNG, said:“Golar is pleased to report Q2 operating revenues of $102.2 […]
Precision BioSciences Reports Second Quarter 2020 Financial Results and Provides Business Update
Dosed First Patient in Phase 1/2a Clinical Trial of PBCAR269A, a BCMA-Targeted Allogeneic CAR T Candidate for Multiple MyelomaPBCAR0191 and […]
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
LEXINGTON, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on […]
Lifeway Foods, Inc. Announces Strong Second Quarter 2020 Results
MORTON GROVE, Ill., Aug. 13, 2020 (GLOBE NEWSWIRE) — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading […]
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions […]
Cerecor Announces Peer-Reviewed Publication Highlighting the Role of the Inflammatory Cytokine, LIGHT, in COVID-19 ARDS
ROCKVILLE, Md. and CHESTERBROOK, Pa., Aug. 13, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ : CERC), a biopharmaceutical company focused […]
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the […]
Passage Bio Reports Second Quarter 2020 Financial Results and Recent Business Highlights
– Submitted IND for PBGM01 Phase 1/2 trial; currently on FDA clinical hold pending additional review of proposed ICM delivery […]
